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ABSTRACT
Monahan, Jennifer Lynn. M.S., Department of Chemistry, Wright State University, 2010
Micro-Raman spectroscopy in diagnosing skeletal pathology in chick embryo tibiotarsi
exposed to platinum group metals.

Platinum group metals (PGMs) have been shown to accumulate in various tissues of
organisms but their toxicity is not well-known. Raman spectroscopy is a powerful
analytical technique that enables direct and non-destructive chemical characterization of
bone tissues. PGMs were injected into chick embryos in the following concentrations:
0.1, 1.0, 5.0, or 10.0 ppm solutions of Pt (IV), Rh (III), Pd (II) or PGMs mixtures (0.1 ppm or
1.0 ppm of each metal). The micro-Raman maps recorded on the paraffin embedded
tibiotarsus cross-sections showed significant changes in the chemical composition and
structure of the bone tissue as a result of PGMs exposure of 1 ppm (i.e., anomalous
calcium inclusions impeding circulation in cartilage matrix). The following bone
properties were analyzed and quantified via micro-Raman spectroscopy: a) age of
mineral crystals and carbonate content, b) degree of mineralization of the collagen matrix
and possible losses in the organic/inorganic bone components and c) mineral crystallinity.
X-Ray fluorescence showed significant changes in the distribution and quantity of
calcium and phosphorus due to the PGM treatments. Flame atomic absorption
spectroscopy also revealed changes in the amount of calcium found in the tibiotarsi. All
three analytical techniques correlated well with each other showing the calcium
inclusions negatively affecting the bone structure of the chick embryo tibiotarsi.
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1. INTRODUCTION
I.

BACKGROUND INFORMATION ON PLATINUM GROUP METALS
The platinum group metals (PGMs) class includes the relatively light triad of ruthenium

(Ru), rhodium (Rh), and palladium (Pd), and the heavier elements osmium (Os), iridium (Ir), and
platinum (Pt). Metallic Os and Ir are not considered biologically important.1 These metals are
found together in sparsely distributed mineral deposits or as by-products when refining other
metals.

The development and expansion of vehicles has raised environmental concerns
over the past decade. Carbon monoxide, hydrocarbon and nitrogen monoxide emissions
from vehicles have been regulated since the 1970s by the use of catalytic converters.2
Catalytic converters use PGMs to oxidize and reduce these emissions.3 Pt and Rh reduce
nitrous oxides to N2 and O2, while Pt and Pd oxidize carbon monixide and hydrocarbons
to carbon dioxide.3 While these metals do aid in reducing the greenhouse gas emissions,
they are now at an increased concentration in the environment.2
These PGMs are emitted as particulate matter that is considered to be nontoxic.3
However, PGMs can form complex salts with other compounds (i.e., halogens, cyanides,
sulfur, hydroxides) and become biologically active.2 Therefore, when PGMs are emitted
from vehicles traveling along the road, the particulate matter is deposited on the
vegetation.3 If these emissions were to form complex salts, then they can be easily
solubilized by rain water and released into various ecosystems.3 A recent study of
automobile emission dust containing Pt, Pd, and Rh particulates found the water soluble
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fraction of Pd and Rh to be in the 7.9-13.2 % range, while the water soluble fraction of Pt
was below 10%. A higher mobility and bioaccumulation are expected for metal elements
that are oxidized to cations in the environment. The higher water soluble fraction for Pd
and Rh suggests that those elements could be more available and thus more toxic than Pt
to the environment and, subsequently, to human health.4 In fact, Pt concentrations in a
selection of foodstuffs obtained from Australia ranged from 0.13 to 8.1 µg/kg fresh
weight.5 Gagnon et al. reported that plant samples collected along roads with only
moderate traffic can accumulate high concentrations of PGMs (e.g., an average
concentration of 14.6 µg of Pt and 0.75 µg of Rh per g of dry weight tissue).2,3
PGMs are introduced into the environment by other means as well, such as from
industrial and medical activities. PGMs are used as catalysts in various industrial
processes (i.e., ammonia oxidation, reforming crude oil, hydrogenation, etc.). The wastes
resulting from these uses enter the ecosystem contain the PGMs in both soluble and
insoluble forms.6 Hospitals and pharmaceutical companies are currently using Pt as an
ingredient in various anti-tumor and anti-cancer drugs. A series of investigations
initiated by Rosenberg et al. to study biological responses to transition metal complexes
found that cisplatinum, cis-[Pt(NH3)2Cl2], has antitumor activity.7 Additionally, certain
Pt complexes are effective antitumor agents by producing severe and persistent inhibition
of DNA synthesis, as well as the slight inhibition of RNA and protein synthesis.1
Once PGMs enter the ecosystems, they have been shown to bioaccumulate in
various tissues, both plant and animal. This provides a potential for adverse effects on
various living organisms, including humans. In general, the environmental impact,
toxicity, and bioavailability of these heavy metals in living organisms remain unclear.6
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PGM accumulation through dietary intake in animal models such as earthworms8
and rats9 has also been documented. The accumulation of PGMs resulted in pathological
and genotoxic responses in all models. The consequential exposure to PGMs in animals
showed changes in adrenal glands, glomeruli of the kidney, and white pulp of the spleen,
while plants exhibited growth inhibition. Humans may be exposed to PGMs by ingestion
through dietary intake or by inhalation of the particulate matter. However, there have
only been a few studies to assess this threat to human health.10 These few studies showed
exposures to PGM emissions cause disease-like symptoms including asthma,
miscarriages, allergic reactions, nausea, loss of hair, and mucous membrane irritations.3,6
Additionally, Pt was found to be the most toxic PGM toward organisms due to its high
affinity to bind to proteins. The World Health Organization showed in 2002 that PGM
compounds might cause severe respiratory conjunctivitis.11
EXPERIMENTAL DESCRIPTION
The proposed experiment will inject developing White Leghorn strain chick
embryos with Pt, Rh, Pd, and a mixture of the three metals as a salt solution. Injections
will be made on the 7th and 14th days of incubation and the embryos will be sacrificed on
the 20th day. Various organs will be harvested and in particular, the tibiotarus will be
fixed, embedded, sliced, and placed on a microscope slide. The tibiotarsus was chosed
for examination via micro-Raman spectroscopy due to the ease of accessibility of this
bone for harvesting. Micro-Raman spectroscopy was utilized in order to study the
morphology and chemical content within the tibiotarsus cross-section. Further studies
using X-Ray fluorescence microscopy and flame atomic absorption spectroscopy were
used to confirm the information gained from the micro-Raman analysis.
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PRELIMINARY RESULTS
Our preliminary experiments exposed developing chick embryos to a singleelement injection of 5.0 ppm Rh. This exposure revealed the formation of calcium
deposits in the brain tissues of developing chick embryos (Figure 1.1). The mechanism
for this response is unknown. In addition, all embryos surviving the sub lethal dose of
5.0 ppm Rh experienced incomplete development of rib cages and/or skulls. Therefore,
this project will focus on the skeletal pathology of tibiotarsi, a model for bone
development, in developing chick embryos exposed to PGMs by micro-Raman
spectroscopy and other complimentary techniques.

Figure 1.1: Calcium deposits (black spots) observed in the brain tissue of developing
chick embryos treated with 5.0 ppm of Rh. The slide was stained using the Von Kossa
protocol.
HYPOTHESIS
It is hypothesized that PGMs may penetrate the cartilage tissue in developing chick
embryos and interfere with calcium metabolism in this tissue.
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SCIENTIFIC AIMS
1.

To show that abnormal calcium inclusions and/or calcium redistribution occur
within the cartilage tissue cross-sections when exposed to PGMs above a specific
threshold level.

2.

To show that PGM exposure levels correlate negatively with calcium content and
morphology in the tibiotarsi of developing chick embryos.

II.

CHICK EMBRYO CARTILAGE COMPOSITION AND MORPHOLOGY
CARTILAGE

The avian model resembles other amniotes, including mammals, in some characteristics
of skeletal development. 12 The embryonal skeleton is initially formed as cartilage, which
ultimately becomes ossified.13 The cartilage is an essential first step to development and
growth of long bones.13 However, the cartilage growth plates disappear when postnatal
growth is over. Cartilage has no capillary blood supply (avascular) of its own so its cells
must obtain oxygen and nutrients by long-range diffusion. The cartilaginous matrix is a
resilient gel-like structure with specific macromolecular organization. Tissue fluids
partially trap and bind matrix constituents, and account for 65% to 80% of the wet weight
of the matrix. The major volume of tissue fluid in the matrix facilitates long-range
diffusion of oxygen and nutrients to chondrocytes from capillaries that lie outside the
cartilage. The long-range diffusion process is essential in gas exchange and waste
removal. Metabolic byproducts of the cartilage tissue follow a reverse diffusion path to
these outside capillaries. Dependence on this long diffusion pathway is hazardous,
especially if matrix proteoglycans become displaced by insoluble calcium salt
inclusions.13
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The embryonic cartilage cells differentiating at the sites of developing cartilages
are called chondroblasts. These cells are responsible for secreting the macromolecular
constituents of the cartilage matrix. Chondroblasts at the periphery of these sites form a
fibrous covering known as perichondrium. The outer perichondric cells differentiate into
fibroblasts, which produce collagen. This fibrous outer layer of the perichondrium
remains in adult life with a few exceptions. For example, articular cartilages are devoid
of perichondrium. The inner part of the perichondric covering is responsible for
chondrogenesis, i.e., the cartilage development. The chondrogenic cover continuously
creates new chondroblasts that built up the collagen matrix. Chondroblasts buried in the
cartilage matrix are described as chondrocytes. Chondrocytes are enclosed in tiny matrix
compartments known as lacunae. Each living chondrocyte virtually fills its lacuna.
Chondrocytes are metabolically very active and essential in the synthesis of numerous
matrix components.8 Mature chondrocytes are large secretary cells with a spherical
nucleus and a prominent nucleolus. Initially their cytoplasm is basophilic, but later it
contains numerous fat droplets and appears vacuolated.13
The cartilage tissue may grow simultaneously in two different ways: interstitial
and appositional. Interstitial growth is characteristic to the cartilage alone and cannot
occur in bone. According to this growth mechanism, the cartilage expands because of the
increase in the population of proliferative chondrocytes and accompanying
supplementary matrix production. Appositional growth may be observed in both
cartilages and bones. According to this growth mechanism, the cartilage expands due to
the increase in the number of chondroblasts from the perichondrium and the
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incorporation of new supplementary matrix constituents that they produce at the outer
layer of the cartilage.13
Collagen accounts for 40% to 70% of the dry weight of the cartilage matrix and is
constituted by abundant type I and type II collagen fibers. Conspicuous parallel bundles
of type I collagen fibers form the fibrocartilage, which resist stretching under extreme
tension. Fibrocartilage is avascular.8 Fine type II collagen fibers together with
acidophilic elastic fibers make up the elastic cartilage, which is adapted to withstand
repetitive bending.13
BONE
Cartilage that undergoes endochondral ossification (i.e., an ossification process
characteristic to long bones) is replaced by bone. In embryonal development, the
tibiotarus is completely formed by day five and ossification occurs shortly thereafter.
The ossification process is completed eleven weeks after hatching. Similar to formation
of the limb skeleton, the skull begins to ossify by day nine of incubation. By the
forteenth day of incubation, most of the skull bones have undergone ossification. During
the later stages of development, the embryo obtains its calcium from the egg shell.13
Four bone cell types: osteogenic stem cells (osteoprogenitors), bone matrix
producers (osteoblasts), bone matrix maintaining cells (osteocytes), and bone matrixresorbing cells (osteoclasts) are present in the chick embryo. Osteoprogenitor cells,
which are stimulated to proliferate, create osteoblasts in regions that are well
vascularized. Osteoblasts are specialized nondiving cells that synthesize and secrete the
organic constituents of the bone matrix. These cells are also implicated in the process of
matrix calcification and have an additional role of mediating the bone resorption. The
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development of osteocytes represent the final stage of maturation of the bone cell lineage
and their function is to maintain the bone matrix in good repair. Osteoclasts are large
nondividing motile cells that help remodeling the bone by resorbing surplus or inferior
bone matrix.13
Similar to the cartilage tissue, the bone tissue contains living cells embedded in an
extracellular matrix that is reinforced by collagen fibrilis. Like chondrocytes, the cells
embedded in the bone matrix, known as osteocytes, occupy lacunae. Another similar
feature is the presence of a fibrous connective tissue covering called periosteum, which is
the counterpart of perichondrium.13
However, in contrast to the cartilage matrix, the bone matrix is heavily calcified
and is constantly replaced throughout the bone remodeling or turnover process. 14 This
makes the bone harder and less supple than the cartilage. Bone matrix withstands
bending, twisting, compression, and stretch. These mechanical properties provide the
structural support and mobility of the avian body and offers protection of vital organs.
Additionally, osteocytes differentiate in regions close to capillaries (i.e., 0.2 mm radius
of a capillary), while chondrocytes are essentially devoid of blood vessels. Therefore, a
clear difference is expected in the way the two types of cells nourish since the high bone
mineral content severely limits the long-range diffusion through the tissue.13
Osteocytes survive in the hostile stone-like bone matrix due to the presence of
canaliculi and the highly vascularized tissue. These canals interconnect the lacunae with
one another and link them to the bone surfaces that are bathed by tissue fluid. Canaliculi
bring tissue fluid, oxygen, and nutrients to all osteocytes. Additionally, the tissue fluid
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produced by blood capillaries reaches the surrounding osteocyte cells by way of the
canaliculi.13
Almost 70% of the wet weight of the bone matrix is bone mineral, primarily
represented by hydroxyapatite. The insoluble calcium salts make the bone rock-hard.
Only 25 % of the bone tissue is water. More than 90% of the organic content of the
bone matrix is given by type I collagen together with small amounts of type V collagen
(i.e., a higher percentage than in the cartilage matrix). Due to higher abundance of
collagen fibrils, the bone matrix is highly resistant to tensile stresses. Other organic
constituents of the bone matrix are glycosaminoglycans, glycoproteins, osteonectin (i.e.,
a protein that anchors bone mineral to collagen), osteocalcin (i.e., a calcium-binding
protein), and other matrix proteins that have the capacity to induce bone formation.13
III.

CHICK EMBRYO MODEL
The chick embryo model has been embraced due to its notable history in various

biological studies (i.e., immunology, genetics, cell biology, embryology, virology, and
developmental biology).15,16 This model has been studied since the time of the ancient
Egyptians and Aristotle in order to understand the development of the chick embryo.16
By the end of the 19th century, scientists began manipulating the chick embryos in order
to understand the developmental potential of the cells.16 This led to detailed fate maps,
formal definition of important concepts, and to the general conclusion that development
depends on the flow of instructive signals between the different cells.16 During the mid
20th century, scientists became more interested in the human, fly, frog, and mouse
genome due to the discovery of gene expression, and the chick embryo model lost
momentum.16 In the late 20th century, another resurgence of the chick embryo model
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arose due to many technological advances in stem cells and genomics research.16 By
2005, the chicken genome sequence was complete and became a popular model system.15
The National Institute of Health (NIH) has recently recognized the chick embryo as a
readily available and well-developed biological model for pharmaceutical and
toxicological studies.17
The chick embryo model was employed in this study due to the well-established and
inexpensive experimental methods associated with it in comparison to other animal
models.17 During chick development, the permeability of the blood-brain barrier changes
during the 21-day gestation cycle.18 Figure 1.2 shows Hamburger and Hamilton’s (HH)
stage 30 and 4019 of the developing chick embryo. At stage 30, the segments of the wings
are clearly seen and bent at the elbow joint.19 The legs are bent and the webs between the
toes are slightly curved.19 The mandibular process is beginning to approach the beak but
the gap is still noticeable.19 The neck has also lengthened drastically between the collar
and the madible.19 The beak may also be seen but is not fully developed.19 At stage 40,
the length of the beak is 4.0 mm and the length of the third toe is 12.7 ± 0.5 mm, which
are important characteristics for the chick to begin hatching.19 The formations of scales
on the inferior and superior surfaces of the legs are also noticeable. The foot is also
covered with well-developed papillae.19 In this study, embryos were injected with
various PGM treatment solutions during these stages. This allowed the chick embryos to
mature with a new treatment medium in place. Chick embryos develop rapidly and are
easily accessible at all stages.11 Lastly, the embryos are not considered vertebrate
animals before hatching. Therefore, no special animal license is required.11
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Figure 1.2: Stage 30 and 40 of the developing chick embryo as observed by Hamburger
and Hamilton. Reprinted from Viktor Hamburger and Howard Hamilton: A Series of
Normal Stages in the Development of the Chick Embryo. Copyright © 2005 John Wiley
and Sons. Used by permission of the publisher, John Wiley and Sons
(www.interscience.wiley.com).19
IV.

RAMAN SPECTROSCOPY
Spectroscopy is a very wide topic, which uses electromagnetic radiation to study

matter. In particular, Raman spectroscopy is a powerful analytical tool, which uses a
monochromatic laser to excite vibrations and rotations in molecules. Therefore, Raman
spectra provide a molecular fingerprint, in which various molecules will lead to different
spectral profiles.20
The Raman effect is an inelastic scattering process that occurs due to the
interaction between the analyte molecules and the photons. By definition, scattering is
the collision of the photon with the molecule in which energy and momentum are
transferred between the photon and the molecule. This scattering process may be elastic
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(Rayleigh) or inelastic (Stokes and anti-Stokes) according to the change in energy
experienced by the photons.20

Figure 1.3: Shows a typical Raman energy diagram.20
As seen in Figure 1.3, during the interaction of the molecules with the excitation
laser light, the potential energy of the molecules is raised to a virtual state (R) above the
ground electronic state. Most of the molecules will immediately return to the ground
state by emitting a photon of the same energy (0) as the incident laser line. This is
denoted as the Rayleigh scattering contribution. However, a very small fraction of the
incident photons (1 in 1012) will experience an inelastic scattering effect, the Raman
Stokes (Stokes) and anti-Stokes (Anti-Stokes) contributions. The Stokes portion of the
Raman spectrum is produced when the molecules return to an excited vibrational/
rotational state. As a result, the scattered photon will have less energy than the incident
one. Molecules that are already in an excited state will undergo similar effects in which
the inelastically scattered photon will have more energy.20
The Raman effect arises due to the change in polarizability (α) of a molecule as a
result of the interaction of molecules with the electric field vector (E) of the laser
radiation (i.e., electromagnetic field), which induces a dipole moment change (µ):
(1.1)
12

Therefore, a change in the polarizibility of the molecule must be present during a
vibration or a rotation in order for the mode to be Raman active. Thus, the symmetry of
the molecule determines the activity of vibrational and rotational modes.20
During vibrations or rotations of a molecule, the polarizability is not constant and
will change with the rotation or vibration frequency, k, and time, t, according to equation
(1.2).
(1.2)
where α0 is the equilibrium polarizability and α is its maximum variation. The incident
electric field varies with time according to equation (1.3).20
(1.3)
Therefore, the induced dipole moment of the molecule is given by
(1.4)

The classical explanation for Rayleigh scattering (0), anti-Stokes lines (0 + k),
and Stokes lines (0 - k) is illustrated by equation (1.4).20 This classical treatment
implies that the intensities of the Stokes and anti-Stokes lines are equal; however, they
depend on the relative number of molecules (n) in the original states.20 Because of this
dependence, the Boltzmann distribution is used to calculate the intensities (I) of the
Stokes and anti-Stokes peaks, shown in Equation (1.5); where h is Planck’s constant, k is
the Boltzmann constant, and T is the temperature.21
3 h
2 kT

 h

I anti Stokes nexcited e

 h  e 2 kT
I Stokes
n ground
e 2 kT

(1.5)
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Infrared (IR) radiation causes an induced dipole change in the molecule.
Therefore, IR spectroscopy is considered a complementary analytical tool to Raman. If a
molecule has a center of symmetry, the mutual exclusion rule is then applied. This states
that if one normal mode is Raman active, then it will be forbidden in the IR and the
opposite condition applies as well. The symmetry group may be used to determine if a
normal mode vibration will be Raman or IR active.20 The normal modes whose
symmetry is the same as the function x, y, or z, will be IR active, while the Raman active
modes will have x2, y2, or z2 function.20
The selection rules for the Raman active vibrational modes are  = ±1 and J =
0, ±2 for linear molecules or J = 0, ±2, K = 0 and J = 0, ±2, K ≠ 0 for symmetric
top molecules, where K is the component of the angular momentum J. The rotational (R)
Raman spectrum give anti-Stokes (J = 2) frequencies for linear molecules according to
equation (1.6)
,

(1.6)

where J’ is the final quantum state and J” is the initial state. While substituting
, the equation becomes
(1.7)
These lines will appear at higher frequencies than the exciting laser frequency and
therefore are denoted as the S branch. Hence, the intensities of these lines are directly
determined by the populations of the initial state. The Stokes (J = -2) frequencies are
given by Equation (1.8).
(1.8)
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These lines are denoted as the O branch lines because they appear at lower frequencies
than the laser excitation line. The Q branch is then given by J = 0.20
The interpretation of Raman spectrum is based upon the law of conservation of
energy as illustrated by Equation (1.9).
(1.9)
This states that the frequency (0) of the incident photon is scattered by a molecule in a
quantum state i of energy Ei. Thus, the frequency of the outgoing photon (f) will end in
a quantum state f of energy Ef. In the Raman effect, the energy of the incident photon
does not need to coincide with a quantized energy difference in the molecule. Therefore,
any laser light frequency (e.g., visible, ultra violet) may be utilized.21
RAMAN DATA

Micro-Raman spectroscopy is a powerful, laser-based analytical technique that
enables direct and non-destructive chemical characterization of molecules in a sample.
Therefore, a Raman spectrum obtained from cells and tissues is an intrinsic molecular
fingerprint of the sample, revealing detailed information about their chemical
composition. Chemical composition of a location of interest may be investigated with
micro-level spatial resolution by coupling the Raman spectrometer with a confocal
microscope. Assessment of bone chemical composition is complicated because of tissue
heterogeneity. In contrast with other well-established techniques for bone analysis such
as X-Ray Diffraction (XRD) and Dual Energy X-Ray Absorptiometry (DEXA), microRaman spectroscopy may address the heterogeneity issue.
Raman peak position, intensity, full width at half maximum (FWHM), and
integrated peak area are known to provide information on the cartilage/bone chemical
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composition and structure. Micro-Raman maps may be used to determine, analyze, and
quantify the following cartilage/bone properties:
a)

age of mineral crystals and carbonate content in cartilage/bone

As mentioned above, cartilage/bone tissue is a composite of an organic matrix and an
inorganic mineralized component. The mineral fraction of cartilage/bone is carbonated
calcium phosphate [Ca5(PO4, CO3(OH)], commonly described as hydroxyapatite (HAP).
Ions such as fluoride, chloride, and magnesium may also be incorporated into the crystal
lattice of the mineralized matrix, depending on the chemical environment and tissue
history. For example, carbonated ions (CO32-) substitute for two anionic sites in the HAP
structure: monovalent OH- sites and trivalent phosphate PO43-. They are known as type-B
(ν1(CO32-) mode at 1070 cm-1) and type-A (ν1(CO32-) mode at 1103 cm-1) substitutions.
In contrast to cartilage, mature bone generally contains more carbonate, and the type-B
carbonate represents the major species.22,23 The ratio of the amount of type-B carbonate
and the amount of phosphate will allow estimating the age of mineral crystals and the
carbonate content in the samples (by calculating the intensities ratio and the integrated
areas ratio: I(CO32- band at 1070 cm-1) / I(PO43-band at 960 cm-1).23,24
b)

inorganic to organic cartilage/bone components ratio (i.e., degree of

mineralization of the collagen matrix) and possible losses in any of the two
cartilage/bone components.
The inorganic component (i.e., the mineral) is usually represented by the strong PO43vibrational modes in the 920-980 cm-1 spectral range, while the organic component of the
bone (i.e., the collagen matrix) corresponds to the amide I vibrational modes in the 16001700 cm-1 region.24 In contrast, cartilage tissue contains both type I and type II (1200-
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1300 cm-1 and 1600-1700 cm-1) collagen fibers. The integrated area of the peaks
corresponding to the inorganic components may be compared with the ones
corresponding to the organic components and the ones determined for the control samples
to estimate the mineral to matrix ratio.
Possible changes in the spectral profile of the vibrational modes of


the PO43- group: ν1(960 cm-1), ν2(430-450 cm-1), ν3(1030-1040 cm-1), ν4(580-590
cm-1)24,25



the CO32- group : ν1(1070 cm-1)24,25,26



the collagen amide I: 1600-1700 cm-1 24,25, 1400-1470 cm-1 24,25,26



the collagen CH groups: stretching modes at 2800-3100 cm-1 24,25



the collagen amide III: 1200-1300 cm-1 24,25

may also be examined to determine if there are any losses in the inorganic and organic
components of cartilage/bone when compared to the control. The Raman spectrum of the
embedding material may be recorded separately and used as a reference to ensure the
correct assignment of the observed bands.26,27
c)

mineral crystallinity

The bandwidth of the ν1(PO43-) symmetric stretching mode at about 960 cm-1 may be
correlated with crystal size. The FWHM of this peak was observed to steadily increase
with decreasing crystal size and smaller crystallinity, i.e. less ordered crystal.28,29 Akkus
et al. showed that the mineral crystallinity of normal rat cortical bone could be
approximated as ≈ 1/bandwidth of the 960 cm-1 peak.29
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V.

X-RAY FLUORESCENCE MICROSCOPY
X-ray fluorescence spectroscopy is a non-destructive, analytical technique that

allows for mapping of the elemental composition of a sample.30 High-energy X-rays
bombard the sample causing the removal of an electron (photoelectric effect) located in
the inner orbitals of the atom. The atom becomes unstable upon the loss of this inner
electron. As a result, an electron from a higher energy level fills the empty orbital. Due
to the energy difference between the two orbitals, a photon is released causing an X-ray
fluorescence emission characteristic to the specific atom. Morphological features of the
sample may be simultaneously identified by attaching an optical microscope to the X-ray
fluorescence system.30
VI.

FLAME ATOMIC ABSORPTION SPECTROSCOPY
The flame atomic absorption spectroscopy technique (Figure 1.4) is credited to Sir

Alan Walsh in 1955.31 This technique makes use of atomic absorption in order to
determine the concentration of a specific metal in a sample. A chemically digested liquid
sample introduced into the nebulizer to be first aerosolized and then atomized (i.e., free,
unexcited ground state atoms) during the combustion processes sustained by the
acetylene-air gas mixture. The electrons absorb the energy emitted from a hollow
cathode lamp (i.e., light of a given wavelength), in which the radiation is specific to the
electronic transition of the metal; therefore, allowing for metal selectivity. The BeerLambert Law is applied in order to determine the metal concentration due to the
reduction in light intensity. A photonmultiplier detects the amount of light transmitted
through the sample.
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As in most analytical instrumentation, the flame atomic absorption spectrometer
must be calibrated and set to specific conditions for the element of interest. A calibration
curve is prepared by analyzing known concentrations of the metal analyte and plotting
their absorption values against the known concentration. The unknown samples
concentrations are then extrapolated from the resultant calibration curve.

Figure 1.4: Flame atomic absorption spectrometer owned by the Department of
Chemistry at Wright State University. (photo courtesy of Garrett VanNess)
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2. EXPERIMENTAL
I.

WHITE LEGHORN STRAIN CHICK EMBRYO MODEL
Six-day old fertile-specific and pathogen free (SPAFAS) white leghorn strain

chick embryos were purchased from Charles River Laboratories International, Inc. Upon
arrival, the air sac poles of the eggs were disinfected by wiping the egg surfaces with
70% isopropanol. The location of the air sac was determined by candling using an
external light source. Holes (1 mm2) were drilled in the external shell only to leave the
internal membranes intact. Tape sealed the holes to prevent air and contaminants from
entering.
The chick embryos were incubated for 20 days at 38 ± 1C with the relative
humidity levels at 50-55%. A drip pan filled with sterile water controlled the humidity
level. The incubator was equipped with an automatic turner , which changed the embryo
position every 4 hours to ensure an even exposure to temperature and humidity. The
developmental phase and vasculature development of the embryos were evaluated by
candling, every 48 hours. Chick embryos without observed developing capillaries were
removed from the incubator and were not used for any further evaluation.
IN OVA INJECTIONS
Injection solutions were prepared as solutions with single metal concentrations (Pt
(IV)

in the form of H2[PtCl6]•6H2O, Rh (III) in the form of RhCl3, and Pd (II) in the form of

PdCl2 salt solutions (SPEX-CertiPrep) or as PGM mixture (an equal portion of all three
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PGMs). Solutions for the single metal injections (Pt (IV), Rh (III), Pd (II)) were prepared at
the following concentrations: 0.1, 1.0, 5.0, or 10.0 ppm and were diluted with phosphate
buffer saline (PBS) solution. The PGM mixture injection solutions (0.1 ppm and 1.0
ppm) were prepared by combining each metal at a concentration of 0.1 and 1.0 ppm and
diluting with PBS solution. All solutions were adjusted to a pH of 7.2 with 0.1 N HCl
and 0.1 N NaOH. The PGM treatment solutions were filtered through a 0.2 m filter
(Whatman GD/X) to remove particulate matter and bacteria.
The injection solutions were administered on the 7th and 14th day of gestation
period according to the developmental stages determined by the HH guide.19 The doses
(1 mL) were injected with a hypodermic needle through the previously prepared 1 mm2
hole into the air sac. The experimental design included ten replicates for each treatment
including two control sets (i.e., no injection and PBS solution treatment at the same pH
value).
SAMPLE COLLECTION
The National Institute of Health Guidelines for the Care and Use of Laboratory
Animals were followed to harvest the chick embryos. The embryos were sacrificed on
the 20th day of incubation by decapitation upon egg removal from incubator. Tibiotarsus
samples were immediately collected and segregated for different analysis: histology,
flame atomic absorption spectroscopy, X-Ray fluorescence spectroscopy, and microRaman spectroscopy.
PATHOLOGICAL ANALYSIS
The gross pathology and microscopic pathology observations regarding
abnormalities and deformities of harvested chick embryos were documented. Gross
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pathology of each chick embryo before dissection was recorded using an Olympus digital
camera. Microscopic pathology was conducted on 4 µm thick cross-sections of the bone
using a light microscope and images were recorded using a Magnafire SP Digital
Camera. The bone slide preparation for histological studies is described below.
MICROSCOPE SLIDE PREPARATION
Micro-Raman spectroscopy slide preparation: The soft tissues were cleaned
from the tibiotarsi, rinsed in PBS, and immediately placed in 10% phosphate buffered
formalin. The phosphate buffered formalin fixed the tissue and hindered post mortem
conditions, such as petrification and autolysis of cells. The tissue dehydration used a
graded series of alcohols: 50% ethanol for 60 minutes, 70% ethanol for 60 minutes, 95%
ethanol for 30-60 minutes, absolute ethanol for 30-60 minutes, and absolute ethanol for
30-60 minutes. Prior to embedding the tissue, a clearing agent removed any remaining
alcohol (two times for 30-60 minutes each) since the alcohol used for the dehydration and
the paraffin used for the embedding do not mixture. A Tissue Tek infiltrator and
dispenser was used to embed the tissue in paraffin wax. Next, the embedded tissue was
placed in an oven at 60C for 60 minutes to permit the wax to fill the empty spaces
within tissue. The infiltrated tissue specimen was positioned in the center and towards
the bottom of the mold to maintain the same position of proximal and distal epiphysis in a
labeled Peel-Away mold filled with melted paraffin. After the paraffin mold cooled, a
Spencer microtome was used to cut the fixed and embedded bone into 4 m slices. The
paraffin tissue, sectioned in ribbons, was carefully emerged in a water bath at 40-44C.
A thin layer of albumen was spread over a microscope slide and the shiny side of the
paraffin embedded tissue was placed on the microscope slide. The slides supporting the
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specimens were heated overnight at approximately 50C on a tissue warmer to facilitate
the coagulation of albumen. The prepared slides were stored in a clean, dry place for the
micro-Raman measurements.32
Histological slide preparation
The previously-described micro-Raman spectroscopy slide preparation was
followed with an additional hemotoxylin staining procedure. After the tissues were
embedded, the paraffin wax was removed by using a hydration series of ethanol (95%,
70%, and 50%) washes followed by a distilled water rinse. The hemotoxylin stain was
used in the last step of the hydration series. The water was removed by using a
dehydration series process employing ethanol (95%), eosin stain, ethanol (70%), ethanol
(50%), and tap water until a blue color persisted. Each of the above ethanol rinses were
approximately 3 minutes. The removal of water is necessary in order for the cover slip to
adhere to the tissue. The stained slides were then moistened with a clearing agent and
mounting medium was placed directly on the tissue. Slowly with gentle pressure, the
cover slip was lowered to the slide to avoid air bubbles. The prepared slides were placed
on a slide warmer in an upright position to dry. The dried slides were stored for
histological analysis.32
CHANGES IN CHONDROCYTE LENGTH
The bone slices were analyzed for chondrocytes length using Magnafire SP
Digital Camera software. The largest diameter across the chondrocyte was measured and
recorded in triplicate for 50 randomly chosen cells in each slide.
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STATISTICAL ANALYSIS
One-Way Analysis of Variance (ANOVA) SPSS (Statistical Package for the
Social Sciences) statistical package was used to test for relationships between
concentration of metals in PGM treatments and tibiotarsus chondrocyte size.
Significance level was determined at p ≤ 0.05 probability by Student-Newman-Keuls
multiple comparison test.
II.

RAMAN INSTRUMENTATION33
A LabRAM HR800 (Horiba Jobin Yvon, Inc.) instrument coupled with a high

resolution confocal optical microscope (Olympus, high stability BX41) was used for the
acquisition of Raman spectra on the bone samples.
Figure 2.1 shows the Raman instrument with the cover removed. An internal HeNe laser (Horiba Jobin Yvon, Inc.) and the corresponding optical entrance are located on
the backside of the instrument. The He-Ne laser is polarized vertically (500:1) and has a
power output of 22.5 mW for the 632.817 nm wavelength. The design of the instrument
also allows for the use of external lasers, which would enter the optical cavity through a
second laser entrance. The laser beam is directed into the iris by two mirrors denoted
here by M1 and M2, which may also be used for the laser alignment. After passing
through the iris, the beam enters an interferential pass-band filter that removes the plasma
lines of the laser and leaves only the 633 nm light. The laser beam meets a set of density
filters, which help reduce the laser intensity if necessary. The density filters are housed
in a wheel which contains six neutral filters with the following optical densities: 0.3, 0.6,
1, 2, 3, and 4. The beam then encounters a second iris and is focused by the lens L1 onto
a pinhole H1 (spatial filter for point mode) with the help of the M6 mirror.
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Figure 2.1: The main components of the LabRam HR800 instrument with the cover
removed. Reprinted from Horiba Jobin Yvon: HR800 User Manual. Used by permission
of the publisher, Horiba Jobin Yvon.33
The laser injection rejection system (LIRS) directs the laser beam onto the notch
filter with aid from the mirror M8. A spacer allows for the notch angle to be changed, so
that the beam is completely reflected towards the sample. Lens L3 converges the beam
onto mirror M9, which is then directed to the sample via the optical microscope objective.
The back scattered radiation follows the same pathway up to the notch filter. The
Rayleigh scattering is reflected at the notch filter (i.e., the excitation laser line is
rejected), while the inelastically scattered light passes through. The image of the Raman
beam is then formed by lens L3 onto the confocal hole, which functions as an adjustable
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pinhole. The confocal hole allows for the separation of the signal from each layer of a
layered sample as well as for removing any contributions from the surrounding medium.
The resulting magnification between the sample and the objective can be
calculated by multiplying the objective magnification used for measurements by 1.4 (e.g.,
100 x 1.4 for the 100x objective). The 1.4 magnification factor is represented by the
focal length (250 mm) of lens L3 divided by the tube length (180 mm) of the Olympus
objectives.
The image from the confocal hole is then projected by lenses L7 and L8 onto the
slit S1 of the spectrograph, which reduces the image by a factor of 5. The shutter, which
is located behind the slit S1, controls the signal that enters the spectrograph. Once the
image enters the S1 slit, the beam is reflected by mirrors M12 and Ms1. A spherical mirror
SP1 of a focal length of 800 mm makes the beam parallel and reflects it onto the grating.
The resultant first order diffraction is collected by mirror SP2 of an 800 mm focal length,
which then focuses the beam onto an open electrode thermo-electric cooled (CCD
detector operating at -69C). Figure 2.2 illustrates the beam pathway through the
instrument.
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Figure 2.2: Schematic showing the pathway of the laser through the LabRam HR800.
Reprinted from Horiba Jobin Yvon: HR800 User Manual. Used by permission of the
publisher, Horiba Jobin Yvon.33
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There are two kinematic gratings located on the spectrograph, namely 1800 or
600 grooves/mm, and mounted onto kinematic interchangeable holders. When the 1800
grooves/mm grating is in use, an internal laser diode can be redirected along the optical
path towards the entrance optics. This is employed for the alignment of the confocal hole
and the position of the laser beam on the sample. A sine bar mechanism is used to cover
a scanning range determined by the grating. For the 1800 grooves/mm grating, the
scanning range is 0 – 950 nm, while for the 600 grooves/mm, the scanning range is 0 –
2850 nm due to the smaller amount of grooves. A grating spectrograph will have a
relatively constant dispersion if measured in nm, but when measuring in cm-1, there is a
strong non-linear 1/2 dependence as illustrated in Equation (2.1).
cm-1

(nm)

(nm)

(2.1)

Resolution depends on the dispersion, the slit width, and the image dimension on the
CCD. The image dimension on the CCD is calculated using Equation (2.2),
(2.2)
in which Wi is the dimension of the image slit on the CCD, Ws is the slit width, i1 is the
incident angle on the grating, and i2 is the diffracted angle on the grating. The accuracy
using the 1800 grooves/mm grating is 1 cm-1 in the 450 – 850 nm spectral range. The
repeatability under normal operating conditions (temperature: 20-25 with variations of
±1C and humidity: ≤ 75%) is one pixel with the CCD camera.
The LabRam HR800 is equipped with a color video camera (UEye, UI-1540-C)
and a fiber optic white light source (Euromex, EK-1), which are used in conjunction with
the optical microscope. The white light source utilizes a halogen bulb and has a
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continuous brightness control that allows for intensity adjustment to view the sample in
real time. A 50/50 beam splitter must be placed between lens L3 and mirror M9 to allow
for the white light to reach the sample and to send the image of the sample to the video
camera with the help of lens L5.
The LabRam HR800 instrument is equipped with a motorized XY mapping stage
(travel range: 100 x 80 mm2 and step size: 0.1 µm) that allows for the use of Raman
mapping and extended video options. The optical Raman microscope is equipped with a
Z motor that can be controlled by either the instrument software or joystick similarly to
the XY stage. This Z-motion (resolution: 0.1µm) option facilitates the depth profile point
Raman measurements on a sample and the signal-to-noise ratio optimization of point
measurements during Raman mapping (through the AutoFocus option: ± 30 µm).
The Raman mapping feature collects Raman spectra at predetermined points
along the sample and then compares the relative intensities of the Raman peaks of interest
to create a color coded image. The color coded image can then be used to interrogate the
molecular composition and heterogeneity of a sample. The Raman maps can be collected
in various shapes (square, rectangle, line, random points) and sizes with pre-set
increments. The AutoFocus option can be employed to account for height differences
within the sample at each point in the Raman map. The SWIFT option allows for rapid
data collection (as fast as 7 ms per point) by moving the stage continuously during
measurements, while the regular Raman mapping option stops and collects a spectrum at
each predetermined point. The extended video option can be used to expand the viewing
area of the objective by moving the XY stage as permitted by the XY domains. The
viewing areas are then spliced together to form the final extended video image.
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VII.

RAMAN MEASUREMENTS
The Raman system was calibrated before each measurement using the 521 cm-1

optical phonon mode (2 transverse and 1 longitudinal) of the lattice structure of silicon.34
The silicon sample was placed onto a glass microscope slide and positioned on the
sample stage. A long working distance 100x objective (Olympus, LMPlanFLN) was
used to focus the laser beam on the sample and to collect the backscattered Raman signal.
The 633 nm output (22.5 mW) of a He-Ne laser was used as the excitation line. The
confocal hole was set at 300 m, and the backscattered Raman signal was recorded using
a 600 grooves/mm holographic grating, a number seven spacer, and an open electrode
thermo-electric cooled CCD detector. The Raman signal at 521 cm-1 was optimized
(approximately 52,000 arbitrary units) using the real time spectrum adjustment mode.
The spectrometer was centered at 730 cm-1 during the real time measurements to avoid
the laser excitation line.
The microscope slides supporting the bone samples were placed onto the microscope
stage and imaged using the 100x objective. Paraffin wax slides were also measured as a
control. All Raman spectra were collected in the 100 – 2000 cm-1 fingerprint spectral
area using the 633 nm He-Ne laser. The laser power at the sample was 15 mW. All other
instrument settings were the same as for the silicon standardization procedure. Point
measurements were first obtained on each sample to determine suitable acquisition times
(3 s). The signal was averaged over two cycles to reduce the noise of the spectra for each
point measurement.
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Once the point measurements were completed, a 15 m cross-section was selected for
Raman mapping measurements on each bone sample. The Raman map was collected in
incremental segments to allow the instrument to rest and to prevent loss of data (Figure.
2.3). The auto focus feature was employed to account for the difference in height at
various points on the bone sample and to optimize the signal-to-noise ratio. This
experimental setup allowed for the analysis of a bone sample to be completed in five to
ten days, depending on the width of the bone section. The Raman maps were collected
using the LabSpec (v. 5) software and processed with the help of the Origin 8 software
package. All spectra were baseline corrected by the user defined option with 20 anchor
points and interpolated using the spline method.

Figure 2.3: Optical image of a control bone sample recorded using the extended video
mode option. The red areas represent the Raman mapping segments of 15 µm wide
cross-section.
IV.

X-RAY FLUORESCENCE
The chick embryo tibiotarsi were cut longitudinally and placed in the X-Ray

fluorescence sample holders that contained an X-Ray specific film. The samples were
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strategically mounted to study both the internal and external sections of the bone as
shown in Figure 2.4. A Horiba XGT-7000 X-Ray Analytical Microscope was used to
collect the X-Ray images and spectra.

Figure 2.4: Picture showing the placement of the tibiotarsi samples in order to study
both the internal and external sections.
V.

FLAME ATOMIC ABSORPTION SPECTROSCOPY
Bone samples which were not fixed and embedded were used to determine the

total calcium content via flame atomic absorption spectroscopy (FAAS, Varian
AA240FS). One bone sample for each single metal dose at 1 ppm and one bone sample
for the PGM mixture at 1 ppm were prepared for FAAS analysis. Prior to sample
preparation, two bone samples for each treatment were preserved in the freezer. The wet
weight was recorded and the dry weight was determined by drying in an oven at 80C for
72 hours.
All glassware was cleaned by an acid bath, base bath, and finally autoclaving. All
utensils and work sufaces were sanitized using ethanol to minimize cross-contamination.
The dried bone samples were ground in a beaker with a glass rod in order to allow the
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chemical digestion to proceed quickly. The sample digestion was started with the
addition of nitric acid (Fisher Scientific, OPTIMA grade) and covered with a watch glass
for approximately 15 minutes. The predigested sample and beaker were placed on a hot
plate and heated to reflux gently for approximatley one hour at 125C. After the sample
was removed from the hot plate and allowed to cool to 80C, 3 mL of hydrogen peroxide
(H2O2, 30%) was added to the solution. The beaker was returned to the hot plate at a
temperature of approximately 80C until the digestion was complete when the solution
became clear. The watchglass was removed and the heating was continued until almost
all the liquid has been evaporated. The sample was immediately removed to prevent
burning. Once the sample was near dryness, 8 mL of nitric acid was added while
swirling. The digested sample was quantitatively transferred to a 10-mL volumetric flask
and diluted to volume with nitric acid (OPTIMA, grade).
The acidified, digested samples were then analyzed for calcium concentration using a
Varian Fast Sequential Flame Atomic Absorption Spectrometer (AA240FS), equipped with
an air-acetylene burner and a calcium hollow cathode lamp (5 mA). The operating
conditions were set as recommended by the manufacturer: wavelength (422.7 nm), slit width
(0.7 nm), air flow rate (2.00 L min-1), and acetylene flow rate (13.50 L min-1). Both the
sample measurement acquisition time and delay time between each measurement were 3
seconds. Each sample was measured in triplicate and the absorbance values were averaged
before extrapolating the calcium concentration from the calibration curve. A blank solution
containing 2% nitric acid was introduced between each sample.
A FAAS reference calcium standard solution of 1.0 x 103 ppm (Fisher Scientific)
was used for the preparation of seven calcium standards of 0.05, 0.10, 0.50, 1.00, 2.5,
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5.00, and 10.00 ppm. Each sample contained 2% nitric acid (Optima grade, Fisher
Scientific) and 0.05% lanthanum chloride (Fisher Scientific). Samples were diluted 100x
(PGMs 1.0 ppm) or 200x (Pt 1.0 ppm, Rh 1.0 ppm, Pd 1.0 ppm). A sample spiked with
0.5 ppm calcium (92% recovery) was analyzed to check for matrix interferences and a
duplicate sample was analyzed (100.1% recovery) to verify accuracy and precision.
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3. RESULTS
Exposure to PGMs affected the morphology, calcium distribution, and calcium
concentrations of the tibiotarsi of chick embryos. As the dose of the PGMs was
increased, the affects to the tibiotarsi were also more pronounced. The correlation
between metal exposure and bone morphological changes in developing chick was
verified with Micro-Raman spectroscopy analysis. In addition, the changes to calcium
distribution along the internal and external longitudinal sections of the bone were shown
by the histopathological analysis and X-Ray fluorescence images. The average calcium
amount per gram of tibiotarsus weight for each sample was determined by FAAS
measurements.
I.

HISTOPATHOLOGICAL ANALYSIS

Gross observations
Gross pathological observations provided evidence on the significant impact of
embryonal exposure to PGMs. The brain was protruding from the underdeveloped skull
with the 5.0 ppm Pt treatment (Figure 3.1A). Chick embryos that were exposed to 10.0
ppm Rh exhibited distinct abnormalities such as development of fully functional pectoral
and abdominal organs exterior to the body cavity. The lethal dose (LD100) for all PGM
treatments was found to be 10.0 ppm, while LD50 was reached for PGMs concentrations
of 5.00 ppm. The chick embryos exposed to 10.0 ppm doses of PGMs exhibited a black
coloration characteristic to tissue necrosis (death).
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Figure 3.1 (label A and B): Abnormally developed chick embryos. A) Brain tissue
exposed due to the underdeveloped skull for the 5.0 ppm Pt treatment. B) Internal organs
found outside the abdominal and pectoral cavities as a result of bone malformations in
embryos treated with 10.0 ppm of Rh.
Histological analysis
Histological analysis of the bone cross-sections was used to determine the size of the
bone cells in tibiotarsi. The average chondrocyte lengths decreased in all PGM
treatments in comparison with the control specimens (Figure 3.2). The smallest
chondrocytes were detected for the 1.0 ppm Rh treatment.

36

Figure 3.2: Length of chondrocyte diameters in the tibiotarsus of chicks embryos
exposed to PGMs. The bar graphs represent the chondrocytes diameter ± SD based on
average diameter of 50 chondrocytes per 3 slides from each of the metals. Diameters
with the same lettersabcd were not statistically different at p ≤ 0.05 probability level as
determined by Student-Newman-Keuls multiple comparison test.
II.

RAMAN DATA
Raman spectra and optical images were obtained from all bone cross-sections of

1.0 ppm PGM treatments along with three controls (i.e., no injection.PBS treatment, and
paraffin wax). The third control slide supporting a paraffin wax section was measured to
determine the possible contributions of the embedding material to the Raman spectra of
the bone samples of interest. Figure 3.3 and Figure 3.4 show the optical image (100x
objective) and the Raman spectrum, respectively, obtained from the paraffin wax control
of the same thickness as the bone cross-section samples. The peaks occuring at 1420,
1442, and 1464 cm-1 were used to produce the original Raman maps (maps A in the
following figures). This allows for a quick determination of the location of the higher
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phosphate content areas. Figures 3.5 and 3.6 show the typical micro-Raman spectra of
the no injection control and the 1.0 ppm PGM mixture treatments when located in an area
of high phosphate content as noted by the 1(PO43-) vibrational mode. The assignments
of all relevant vibrational bands are found in Table 1.

Figure 3.3: Optical image of the paraffin control sample recorded using the 100x
objective of the confocal Raman microscope.
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Figure 3.4: Micro-Raman spectrum of the paraffin wax control along with all peaks of
interest assigned.

Figure 3.5: Micro-Raman spectrum from the no injection control sample with all the
peaks of interest assigned (PO34- at 960 cm-1, CO32- at 1070 cm-1, amide I at 1680 cm-1
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and the paraffin modes). It should be noted that the CO32- at 1070 cm-1 overlaps with the
paraffin vibrational mode at 1062 cm-1.

Figure 3.6: Micro-Raman spectrum from the 1.0 ppm PGM mixture sample with all the
peaks of interest assigned.
Table 3.1: Tentative Raman band assignments for the tibiotarsi samples.
(Abbreviations: vs, very strong; s, strong; m, medium; w, weak; vw, very weak; sh,
shoulder; , stretching; , bending; , twisting).
*Non-referenced assignments were observed in the paraffin control to determine its
contribution in the treated samples.
Band Position (cm-1) Tentative Band Assignment
271
paraffin
418
paraffin
43035
2 (PO43-) – symmetric P-O stretch
528
paraffin
58325
 (PO43-) – symmetric P-O stretch
59025
4 (PO43-) – symmetric P-O stretch
25
609
4 (PO43-) – symmetric P-O stretch
645
paraffin
25
673
(CCH);  (CCO)
715
paraffin
808
paraffin
81525
C-O-O);  (C-C) of backbone skeletal vibrations
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85525
87625
891
92125
96125
100425
103225
104525
106326
107125
110319,20
113326
117226
117525
120525
124525
127025
129626
131825
134025
138025
141826
141825
142625
144126
145125
1463
1613
1658 20,25
1667 20,25

(C-C) of hydroxyproline ring
(C-C) of proline ring
paraffin
(C-C) of proline ring
1 (PO43-) – symmetric P-O stretch
Phenylalanine, paraffin
Phenylalanine, paraffin
3 (PO43-) – antisymmetric P-O stretch
(CC) skeletal stretch, paraffin
 (CO32-) – type B
ν1(CO32-)
(CC) stretch, paraffin
 (CC) stretch, paraffin
 (CCC) – out of phase, paraffin
Tyrosine
amide III)
(NH) – amide III
CH2 deformation, paraffin
(CH2)
(CH2)
(CH2), paraffin
C deformation
(COO-)
(CH2), paraffin
CH2 deformation
(NH2)
paraffin
paraffin
(C=O) amid I (-helix)
Amid I ( sheet)

The optical image (10x objective) of the no injection control bone sample is
shown in Figure 3.7. The bone tissue section marked in red delimits the area studied
using the Raman mapping feature. The Raman mapped areas were determined by finding
an area of phosphate within the cross-section. The Raman maps used for this study are
depicted in Figure 3.8. The maps are generated by comparing a) the paraffin wax
characteristic mode at 1400-1515 cm-1 (red color code) to the 1(PO4-3) stretching at 960
cm-1 (green color code), b) the type-B carbonate stretching peak at 1070 cm-1 (red color
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code) to the 1(PO4-3) vibrational mode (green color code), and c) the collagen amide I
band at 1667 cm-1 (red color code) to the 1(PO4-3) vibrational mode (green color code).
These maps indicate a small amount of phosphate in the periosteum of the tibiotarsi and
none in the bone marrow cavity.

Figure 3.7: Optical image of the no injection control bone sample recorded using the
10x objective of the confocal Raman microscope. The outlined area in red indicates
where the Raman mapping was performed.

Figure 3.8: Raman mapping images generated for the no injection control bone sample
by comparing A) the paraffin deformations (1400-1515 cm-1, red) to the 1(PO43-)
stretching band (960 cm-1, green), B) the type B carbonate stretching mode (1070 cm-1,
red) to the 1(PO43-) vibrational mode (960 cm-1, green), and C) the collagen amide I peak
(1667 cm-1, red) to the 1(PO43-) (960 cm-1, green) vibrational mode.
Figure 3.9 shows the optical image (100x objective) of the PBS control bone
sample. The red rectangle indicates the Raman mapped area. The Raman maps of the
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PBS control sample are illustrated in Figure 3.10. These maps are created by comparing
a) the paraffin wax deformations at 1400-1515 cm-1( red color code) to the 1(PO4-3)
vibrational mode at 960 cm-1 (green color code), b) the type-B carbonate stretching mode
at 1070 cm-1 (red color code) to the 1(PO4-3) stretching band (green color code), and c)
the collagen amide I peak at 1667 cm-1 (red color code) to 1(PO4-3) vibrational mode
(green color code). The Raman maps indicate increased amount of phosphate within the
periosteum and bone marrow cavity.

Figure 3.9: Optical image of the phosphate buffer solution control bone sample recorded
using the 10x objective of the confocal Raman microscope. The outlined area in red
indicates tha area of Raman mapping.
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Figure 3.10: Raman mapping images generated for the phosphate buffer solution control
bone sample by comparing A) the paraffin deformations (1400-1515 cm-1, red) to the
1(PO43-) stretching band (960 cm-1, green), B) the type B carbonate stretching mode
(1070 cm-1, red) to the 1(PO43-) vibrational mode (960 cm-1, green), and C) the collagen
amide I peak (1667 cm-1, red) to the 1(PO43-) (960 cm-1, green) vibrational mode.
Figure 3.11 shows the optical image (100x objective) of the 1.00 ppm Pt treatment bone
sample. The red inset delimits the Raman mapped area. The corresponding Raman maps
are inserted in Figure 3.12. The Raman maps are created by comparing a) the paraffin
wax deformations at 1400-1515 cm-1( red color code) to the 1(PO4-3) vibrational mode at
960 cm-1 (green color code), b) the type-B carbonate stretching mode at 1070 cm-1 (red
color code) to the 1(PO4-3) stretching band (green color code), and c) the collagen amide
I peak at 1667 cm-1 (red color code) to 1(PO4-3) vibrational mode (green color code).
The Raman maps indicate an increased amount of phosphate in only the periosteum.
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Figure 3.11: Optical image of the 1.0 ppm Pt treatment bone sample recorded using the
10x objective of the confocal Raman microscope. The area outlined in red indicates the
area of Raman mapping.

Figure 3.12: Raman mapping images generated for the 1.00 ppm Pt treatment bone
sample by comparing A) the paraffin deformations (1400-1515 cm-1, red) to the 1(PO43-)
stretching band (960 cm-1, green), B) the type B carbonate stretching mode (1070 cm-1,
red) to the 1(PO43-) vibrational mode (960 cm-1, green), and C) the collagen amide I peak
(1667 cm-1, red) to the 1(PO43-) (960 cm-1, green) vibrational mode.
Figure 3.13 shows the optical image (100x objective) of the 1 ppm Rh treatment
bone sample and the Raman mapped area (marked with a red rectangle). A closer
examination of the optical image reveals an unclean cut of the sample and confirms the
softness of the bone tissue that was experienced during the microtome cutting process.
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The corresponding Raman maps are inserted in Figure 3.14. The Raman maps are
created by comparing a) the paraffin wax deformations at 1400-1515 cm-1( red color
code) to the 1(PO4-3) vibrational mode at 960 cm-1 (green color code), b) the type-B
carbonate stretching mode at 1070 cm-1 (red color code) to the 1(PO4-3) stretching band
(green color code), and c) the collagen amide I peak at 1667 cm-1 (red color code) to
1(PO4-3) vibrational mode (green color code). The Raman maps indicate an increased
amount of phosphate only within the periosteum.

Figure 3.13: Optical image of the 1.0 ppm Rh treatment bone sample recorded using the
10x objective of the confocal Raman microscope. The outlined area in red indicates the
area of Raman mapping.
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Figure 3.14: Raman mapping images generated for the 1.00 ppm Rh treatment bone
sample by comparing A) the paraffin deformations (1400-1515 cm-1, red) to the 1(PO43-)
stretching band (960 cm-1, green), B) the type B carbonate stretching mode (1070 cm-1,
red) to the 1(PO43-) vibrational mode (960 cm-1, green), and C) the collagen amide I peak
(1667 cm-1, red) to the 1(PO43-) (960 cm-1, green) vibrational mode.
Figure 3.15 demonstrates the presence of an area of high mineral content in the 1 ppm Rh
treatment bone sample. The optical image A) of this area shows abnormal morphology
for the Rh treated tissue in comparison to the control sample. The Raman map B)
confirms the existence of an abnormal highly crystallized area in the same location. The
Raman spectrum C) demonstrates the “green” region of the Raman map has an unusually
high content of calcium phosphate. The Raman spectrum D) shows that the red section
of the Raman map is mainly made off paraffin wax.
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Figure 3.15: An area of an unusually high phosphate content found in the 1 ppm Rh
treatment bone sample. A) Optical image recorded using the 100x objective of the
confocal Raman microscope, B) Raman map (paraffin deformations are marked with red
and the 1(PO43-) band is color coded in green), and C) the Raman spectrum of the high
phosphate area D) the Raman spectrum of the paraffin area.
Figure 3.16 shows the optical image (100x objective) of the 1 ppm Pd treatment
bone sample. The bone tissue section marked in red delimits the area studied using the
Raman mapping feature. The corresponding Raman maps are inserted in Figure 3.17.
The Raman maps are created by comparing a) the paraffin wax deformations at 14001515 cm-1 (red color code) to the 1(PO4-3) vibrational mode at 960 cm-1 (green color
code), b) the type-B carbonate stretching mode at 1070 cm-1 (red color code) to the
1(PO4-3) stretching band (green color code), and c) the collagen amide I peak at 1667
cm-1 (red color code) to 1(PO4-3) vibrational mode (green color code). The Raman maps
indicate an increased amount of phosphate within the periosteum.
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Figure 3.16: Optical image of the 1.0 ppm Pd treatment bone sample recorded using the
10x objective of the confocal Raman microscope. The outlined area in red indicates the
area of Raman mapping.

Figure 3.17: Raman mapping images generated for the 1.0 ppm Pd treatment bone
sample by comparing A) the paraffin deformations (1400-1515 cm-1, red) to the 1(PO43-)
stretching band (960 cm-1, green), B) the type B carbonate stretching mode (1070 cm-1,
red) to the 1(PO43-) vibrational mode (960 cm-1, green), and C) the collagen amide I peak
(1667 cm-1, red) to the 1(PO43-) (960 cm-1, green) vibrational mode.
Figure 3.18 shows the optical image (100x objective) of the PGM mixture
treatment bone sample and the Raman mapped area (marked with a red rectangle). A
closer examination of the optical image shows irregularities at the outer edges of the bone
which were not detected in the control sample without an injection. Furthermore, this
particular bone sample does not seem to have a bone marrow cavity. The corresponding
Raman maps are inserted in Figure 3.19. The Raman maps are created by comparing a)
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the paraffin wax deformations at 1400-1515 cm-1( red color code) to the 1(PO4-3)
vibrational mode at 960 cm-1 (green color code), b) the type-B carbonate stretching mode
at 1070 cm-1 (red color code) to the 1(PO4-3) stretching band (green color code), and c)
the collagen amide I peak at 1667 cm-1 (red color code) to 1(PO4-3) vibrational mode
(green color code). The Raman maps indicate an increased amount of phosphate within
the periosteum and the bone marrow cavity.

Figure 3.18: Optical image of the 1.0 PGM mixture treatment bone sample recorded
using the 10x objective of the confocal Raman microscope. The outlined area in red
indicates the area of Raman mapping.

Figure 3.19: Optical image of the 1.0 ppm PGM mixture treatment bone sample
recorded using the 10x objective of the confocal Raman microscope. The outlined area
in red indicates where the Raman mapping was performed.
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The Raman data also revealed information about: a) the age of mineral crystals
(carbonate content), b) degree of mineralization of the collagen matrix, and c) mineral
crystallinity. The age of the mineral crystals was determined from the ratio of relative
intensities of the 1(CO32-) band at 1070 cm-1 compared to the 1(PO43-) band at 960 cm-1.
This value decreases when exposed to the 1.0 ppm Pd and Rh treatments, increases with
the 1.0 PGMs treatment, and stays the same with the 1.0 ppm Pt and PBS treatments
when compared to the control. The degree of mineralization of the collagen matrix
values were calculated from the integrated areas of the 1(PO43-) band at 960 cm-1 to the
-amide I vibrational mode at 1670 cm-1. This value decreases with the 1.0 ppm Pt, and
stays the same (due to very large uncertainties) for all other treatments when compared to
the control. The last value that was determined was the mineral crystallinity which is
directly related to the full width at half maximum (FWHM) of the 1(PO43-) band at 960
cm-1. This value statistically does not change due to the metal treatments. These
caluclated values are found in Table 3.2
Table 3.2: Calculated values for the age of mineral crystals, degree of mineralization of
the collagen matrix, and mineral crystallinity from eight micro-Raman spectra collected
in areas of interest for each treatment.
*Age of Mineral
Degree of Mineralization
Mineral
Crystals*
of the Collagen Matrix
Crystallinity (cm-1)
0.52 ± 0.28
3.4 ± 1.0
12.0 ±0.9
Control
1.7 ± 1.4
4.7 ± 2.2
13.7 ± 1.8
PBS
1.8 ± 0.9
1.0 ± 0.7
12.3 ± 0.8
Pt
0.06 ± 0.03
2.3 ± 1.3
12.1 ± 0.7
Rh
0.005 ± 0.001
6.4 ± 5.0
12.4 ± 0.59
Pd
2.3 ± 0.9
4. 5 ± 2.1
13.5 ± 1.4
PGMs
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III.

X-RAY FLUORESCENCE DATA
The following gross observations were made in relation to the mechanical

properties of the tibiotarsi during longitudinal sectioning for X-Ray fluorescence
measurements:
a) For all Pt treatments of 0.1 ppm, the tibiotarsus length was longer in comparison with
the control sample. The following values represent the percent increase in length
compared to the no injection sample: 0.1 ppm – 25.56%, 1.0 ppm – 11.28%, 5.0 ppm
– 9.78%, and 10.0 ppm – 4.17%. The exception to this trend was the 10.0 ppm Pt
(dead) sample, which decreased in length compared to the control (7.78% decrease).
For Pt treatments higher than 0.1 ppm, the tissue specimens were noticeably softer
and a clean cut was difficult to obtain.
b) For all Rh treatments, tibiotarsi were longer than the corresponding control
specimens. The following values represent the percent increase in length compared
to the no injection sample: 0.1 ppm – 26.50%, 1.0 ppm – 23.33%, 5.0 ppm – 9.83%,
and 10.0 ppm – 18.33%.

For Rh exposures of 0.1 ppm and 1.0 ppm, tibiotarsi could

be easily sectioned, while for Rh exposures of 5.0 and 10.0 ppm, it was difficult to
obtain a clean cut due to softer bone tissue.
c) For the 1.0 ppm Pd treatment, the tibiotarsi had approximately the same length as in
the control sample, whereas the 5.0 ppm Pd treatment caused a 13.50% increase in
tibiotarsus length. The two bone samples were harder, which allowed for easier
sectioning.
d) For the PGM mixture concentrations, tibiotarsi were longer (0.1 ppm – 22.94% and
1.0 ppm – 19.72%) and thinner in comparison to the control.
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Tibiotarsus lengths are found in Table 3.3. These lengths were determined from the XRay fluorescence optical images by using a ruler and the provided scale bar. It should be
noted that the high standard deviation for the 5.0 ppm Pt treatment was due to inaccurate
measurements caused by the light reflecting on the X-Ray film.
Table 3.3: Lengths of the chick embryo tibiotarsi
Treatment

Length (mm)

No injection
0.1 ppm Pt
1.0 ppm Pt
5.0 ppm Pt
10.0 ppm Pt
10.0 ppm Pt (dead)
0.1 ppm Rh
1.0 ppm Rh
5.0 ppm Rh
10.0 ppm Rh
1.0 ppm Pd
5.0 ppm Pd
0.1 ppm PGMs
1.0 ppm PGMs

18.00 ± 0.48
22.60 ± 0.53
20.03 ± 0.53
19.76 ± 1.46
18.75 ± 0.36
16.60 ± 0.44
22.77 ± 0.61
22.20 ± 0.17
19.77 ± 0.12
21.30 ± 0.10
17.68 ± 0.33
20.43 ± 0.21
22.13 ± 0.06
21.55 ± 0.51

% Difference from
no injection
25.56 ± 2.35
11.28 ± 2.65
9.78 ± 7.39
4.17 ± 1.92
7.78 ± 2.65
26.50 ± 2.68
23.33 ± 0.77
9.83 ± 0.61
18.33 ± 0.47
2.06 ± 1.87
13.50 ± 1.03
22.94 ± 0.27
19.72 ± 2.37

Calcium, one of the major elements in bone, was examined in relation to the PGM
exposure level. The X-Ray fluorescence data obtained on the longitudinal sections
revealed that the distribution of calcium in developing chick tibiotarsus was influenced
by the PGM exposure.
a) For the Pt treatment (Figure 3.20), calcium content seems to decline steadily with
increasing metal concentration except for the 5.0 ppm Pt treatment, where the calcium
deposition increased. The most dramatic changes were observed for the bone marrow
cavities where almost no calcium was detected. The chick embryo marked as “dead”
in Figure 3.21 was found to be undeveloped at the time of harvesting. It can be easily
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noticed that calcium content is increased in the distal end of the tibiotarsus outer and
inner sections.
b) For the Rh treatments (Figure 3.21), onset of calcification was detected at an
exposure level of 0.1 ppm, in particular at the distal end of the periosteum (i.e., the
external dense membrane composed of fibrous connective tissue closely wrapping the
bone marrow). Small calcium depositions were also found in the bone marrow
cavities for the 0.1 ppm treatment. For Rh treatments of 1.0 ppm and higher, the
calcium content steadily decreased in the inner and outer tibiotarsus portions with the
increase in Rh concentration. The most significant changes were observed within the
bone marrow cavities, which were depleted of calcium.
c) For the Pd treatment of 1.0 ppm (Figure 3.22), larger calcium deposits were recorded
in periosteum in comparison with the control tibiotarsus sections. Bone marrow
cavities seemed to have a slightly higher content of calcium than the control sample.
For the Pd treatment of 5.0 ppm, a similar slight decrease in the calcium content was
noticed in comparison with the control sections. Unfortunately, for the 0.1 and 10.0
ppm Pd treatments there were not enough samples to be analyzed via X-ray
fluorescence. This was due to the smaller amount of viable chick embryo eggs for
these treatments.
d) For the PGM mixture treatment of 0.1 ppm (Figure 3.23), a larger calcium deposition
was detected in the distal periosteum and central bone marrow cavities of the
tibiotarsus in comparison with the control sample. A similar calcium distribution
pattern was noticed for the PGM mixture treatment of 1.0 ppm, but of lower intensity.
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Figure 3.20 X-Ray fluorescence image of the entire Pt treated bone samples showing the
amount of calcium present. The magnitudes of the scale bar were increased ten-fold in
comparison to the following figures. This accounts for the differences seen in the control
sample. These measurements will be repeated. The inner portion of the tibiotarsi is
located on the left side for each treatment.

Figure 3.21: X-Ray fluorescence image of the entire Rh treated bone samples showing
the amount of calcium present. The inner portion of the tibiotarsi is located on the right
side for each treatment.
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Figure 3.22: X-Ray fluorescence image of 1.0 ppm Pd, 5.0 ppm Pd, 0.1 ppm PGMs, and
1.0 ppm PGMs treated bone samples showing the amount of calcium present. The inner
portion of the tibiotarsi is located on the right side for each treatment.
IV.

ATOMIC ABSORPTION DATA
The average amount of calcium in the cartilage/bone samples was determined via

FAAS. The instrument was calibrated using seven known standards of 0.1, 0.2, 0.5, 1.0,
2.0, and 4 ppm of calcium (Figure 3.23). One no injection control tibiotarsi was analyzed
and two metal treatment samples were analyzed. Equation 3.3 was used to determine the
average calcium content (µg/g) within the sample, where C is the raw average calcium
content (mg/L), V is the volume (mL) of the undiluted original sample, dnfn is the dilution
factor (put the signal from the sample on scale and within the calibration curve
produced), and W is the weight of the original dry sample in grams.
(3.3)
This value is converted to percent calcium. The percent calcium determined for the
control sample was16.1%. Table 3.4 shows the percent calcium calculations for the PGM
treatments. The percent calcium values were significantly decreased for the 1.0 ppm Pt
and PGMs mixture treatment samples whereas the 1.0 ppm Pd treatment showed a drastic
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increase in comparison to the no injection control. The 1.0 ppm Rh treatment only
increased by 1.2%.

Absorbance (AU)

FAAS
0.45
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0

y = 0.0408x + 0.0078
R² = 0.9991

0

2

4

6
Calcium (ppm)

8

10

Figure 3.23: Flame atomic absorption spectroscopy calibration curve constructed using
seven calcium standards of 0.1, 0.2, 0.5, 1.0, 2.0, and 4 ppm.
Table 3.4: Percent calcium content found in all 1.0 ppm PGM treatments.
Sample Description

Average % Calcium

Control
Pt 1.0 ppm
Rh 1.0 ppm
Pd 1.0 ppm
PGMs 1.0 ppm

16.1 ± 0.2
8.88 ± 0.29
17.8 ± 0.3
24.3 ± 0.4
13.9 ± 0.1
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4. DISCUSSION
I.

HISTOPATHOLOGY

Gross Pathology
Initial gross pathological observations of developing chick embryos exposed to
PGMs were devastating. Striking abnormalities such as brain protrusion from the skull
(figure 3.1A) and formation of abdominal organs outside of the body cavity (figure 3.1B)
were witnessed for all PGM treatments higher than 1.0 ppm. These deformities are
clearly the result of severe bone malformations. A properly formed skull should
withstand the pressure created by a developing brain and its surrounding fluids.
However, if the skeleton does not present the expected mechanical properties (i.e.,
hardness, elasticity, roughness, and strength) and morphology (i.e., age of mineral
crystals, degree of mineralization of the collagen matrix, and mineral crystallinity), it will
not withstand bending, stretching, twisting, and compression. Therefore, the brain easily
splits the top of the skull with little or no resistance. Similarly, if the development of rib
cage is hindered due to the PGM exposure, a lack of internalization of abdominal organs
will be experienced. Ribs develop normally in the membrane during embryonic
development at the end of day 6, become cartilaginous by day 7.5, and ossify by day 12.
The ossification process of the rib cage was not normal or completed in the chick
embryos exposed to PGMs over 1 ppm.
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Histology
Exposure to PGMs had adverse effects upon the development of chondrocyte
cells in cartilage. Histological analysis revealed a decrease in the chondrocyte diameters
in all PGM treatments. Knowing that chondrocytes have an essential role in the synthesis
of various matrix constituents, an abnormal cartilage development is expected due to
these developmental changes. This histological observation further supports the gross
pathological observations. More studies are necessary provide a detailed mechanism for
the decreased chondrocyte diameters.
II.

RAMAN SPECTROSCOPY
The micro-Raman spectrum of the paraffin wax control (Figure 3.4) was first

collected to determine the contributions of the embedding material to the spectra of all
tibiotarsi. Two micro-Raman spectra obtained from the no injection control and 1.0 ppm
PGM mixture sample were inserted in Figure 3.5 and 3.6 for comparison reasons. A
detailed vibrational assignment was prepared in Table 3.6 for each significant band in the
micro-Raman spectra according to literature. This allowed for the identification of the
paraffin wax characteristic vibrational modes (271, 418, 528, 645, 715, 808, 1003, 1033,
1064, 1137, 1174, 1299, 1372, 1420, 1442, 1464, and 1613 cm-1).
During initial measurements, the paraffin embedding material at 1400-1515 cm-1
was compared to the 1(PO43-) band at 960 cm-1 to identify the regions of possible higher
mineral content. Calcium mineral in hydroxyapetite is indirectly determined in the
Raman spectrum based on the phosphate vibrational mode. As expected, regions of
unusually high calcium inclusions were sporadically found in the tibiotarsus crosssections for all PGM treatments. The no injection control sample (figure 3.8) exhibited a
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few areas of high crystallization at the outer edges of the bone. However, this was
expected because those periosteum regions usually contain ossified bone. In contrast to
the no injection control sample, the PBS treatment (figure 3.10) led to the formation of
abnormal calcium inclusions within the bone marrow cavity. In all three 1.0 ppm
individual metal treatments (i.e., Pt, Rh, and Pd), areas of unusual high mineral content
were found within the outer edges of the bone (figures 3.12, 3.14 and 3.17). These areas
were of increased size and quantity in comparison to the no injection control. The 1.0
ppm PGM mixture treatment caused an increase in mineral content throughout the whole
bone cross-section (figure 3.19). However, the observed abnormal increase in mineral
content due to the PBS treatment, this may be causing a systematic increase in all the
metal treatments.
According to Bellairs and Osmon, the precartilaginous precursors of tibiotarsus
are formed by day five and ossification begins on day six.12 The ossification process is
completed by the 11th week after hatching.12 Because the tibiotarsi are mostly composed
of cartilage during development, nutrients and waste are transported through long range
diffusion.13 Therefore, the presence of abnormal calcium inclusions may inhibit the
transport of essential nutrients, oxygen and waste through the matrix, and may cause
blockages of the vasculatore system during the pre-hatching phase of chick development.
Ultimately, these effects may lead to the observed skeletal deformities in the growing
embryo exposed to PGMs.13
As shown in the Raman Data section (table 3.2), specific Raman band features are
used to estimate: A) the age of mineral crystals, B) the degree of mineralization of the
collagen matrix, and C) the mineral crystallinity.
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a)

The calculations for determining the age of mineral crystallinity revealed a drastic

decrease in the Rh and Pd exposures but an increase in the PGMs mixture treatment. It is
important to realize the age calculated due to the PBS exposure has an abnormally high
uncertainty value. Because the PBS sample is another control, no definitive conclusion
can be determined at this time due to this high uncertainty value.
b)

The signal-to-noise ratio in the 1600-1700 cm-1 spectral region, characteristic to

amide I collagen vibrational modes, was very low for the chosen Raman-mapping
acquisition time of three seconds. This resulted in high uncertainties for the calculated
inorganic versus organic matrix components ratio. Even with the low signal-to-noise
ratio and the resulting high uncertainties, a small decrease in the degree of mineralization
was established for the 1.0 ppm Pt treatment sample. As it will be shown later in the
FAAS discussion section, the largest calcium mineral loss was detected for the 1.0 ppm
Pt treatment. This calcium loss provides more evidence for the observed skeletal
pathological changes. Point Raman measurements of longer acquisition times will be
performed to re-evaluate the inorganic versus organic matrix ratios for the other metal
treatments.
c)

The changes estimated in mineral crystallinity for all metal treatments as

compared to the no injection control sample is inconclusive at this time when accounting
for the spatial resolution of the micro-Raman instrument for the 600 groove/mm
holographic grating is 1.1 cm-1 and the calculated uncertainties that are within the same
wavenumber range.
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III.

X-RAY FLUORESCENCE MICROSCOPY
X-Ray fluorescence images (figures 3.20 – 3.22) showed a significant

redistribution of calcium within the chick embryo tibiotarsi as compared to the no
injection control sample. Specifically, regions of unusual high calcium content were
identified in the periosteum of tibiotarsi for all 1.0 ppm metal treatments including PGM
mixture as well as in the bone marrow cavity for PGM mixture alone. These results
confirm the calcium redistribution pattern revealed by the Raman-mapping observations
for all 1.0 ppm treatments and controls (figures 3.8, 3.12, 3.14, 3.17. and 3.19).
IV.

FLAME ATOMIC ABSORPTION SPECTROSCOPY
The FAAS measurements of tibiotarsi of chick embryos exposed to PGMs

revealed a significant decrease in the average percent calcium with respect to the no
injection control sample for the 1.0 ppm Pt and PGM treatments (Table 3.4). The largest
percent calcium difference from the no injection control was determined to be 55.1% for
the 1.0 ppm Pd treatment. This was followed by 44.8 % for the 1.0 ppm Pt, 13.7 % for
the 1.0 ppm PGMs, and 10.6 % for 1.0 Rh treatment. The observed decrease in average
calcium content is indicative of an overall loss in bone mineral density making the bone
much weaker than it should be. In contrast, the increase in the average calcium content
reveals older, more brittle bone in comparison to the control. It is now obvious that the
presence of PGMs is directly correlated with the enormous loss and redistributions in
bone mineral density and may explain the observed morphological and pathological
changes in the chick skeleton (i.e., limb deformities, smaller chondrocyte cells, etc.).
Unfortunately, an exact mechanism explaining these enormous losses in calcium is not
known at this time.
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V.

CONCLUSIONS
The widespread use of PGMs raises concerns for potential adverse health effects

in living organisms. It has been documented that PGMs are readily bioaccumulated into
plant tissue, allowing for these metals to enter the food chain of animals and humans.36,37
In this study, we examined the skeletal pathology of tibiotarsi in chick embryos exposed
to platinum group metals by micro-Raman spectroscopy, X-ray fluorescence, and flame
atomic absorption spectroscopy. This research has shown that exposure to PGMs is
detrimental to chick embryo skeletal development. This observation was expected due to
the small quantity of toxicity studies on PGMs present in literature.1-10 Micro-Raman
spectroscopy revealed the formation of abnormal calcium deposits within the cartilage
matrix of chick embryo tibiotarsi for all 1.0 ppm metal treatments. X-ray fluorescence
measurements confirmed the Raman data and calcium redistribution pattern observed
within the periosteum and bone marrow cavity of tibiotarsi. Flame atomic absorption
spectroscopy showed enormous decreases in the average percent calcium for all platinum
group metal treatments, which further explains the observed limb deformities and
decrease in chondrocyte cell diameter. Micro-Raman spectroscopy in combination with
X-ray fluorescence spectroscopy and flame atomic absorption spectroscopy were
successful analytical techniques for the investigation of chick embryo skeletal pathology.
Because chick embryos are in the family of amniotes, the potential for similar effects to
other animal species, including pregnant woment, may be possible.
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VI.

FUTURE ENDEAVORS
Further analysis should be continued in order to understand the toxicological

effects of PGMs on the chick embryo animal model. Some scientific aims that are of
interest for a future graduate student are:
1) To complete the micro-Raman spectroscopy and FAAS investigations on
tibiotarsi for the other PGM exposure levels (0.1 ppm, 5.0 ppm, and 10.0
ppm), and to correlate these results with the already collected X-Ray
fluorescence data and observed pathological changes.
2) To develop a computer software program for the complete analysis of the
micro-Raman maps.
3) To observe and measure the PGMs bioaccumulation in the cartilage tissue of
developing chick embryos.
4) To examine the effect of part per million versus molarity doses due to the
differences in weights of the three metals.
5) To examine the relationship between the PGMs bioaccumulation and the
induced morphological changes within the entire tibiotarsi.
6) To explore the possible mechanism(s) explaining the detrimental role of
PGMs on the chick skeletal development.
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